Upregulation/NN
of/IN
c-Fos/NN
in/IN
activated/VBN
T/NN
lymphoid/JJ
and/CC
monocytic/JJ
cells/NNS
by/IN
human/JJ
immunodeficiency/NN
virus-1/NN
Tat/NN
protein/NN
./.

The/DT
regulatory/JJ
Tat/NN
protein/NN
of/IN
the/DT
human/JJ
immunodeficiency/NN
virus/NN
type-1/NN
(/(
HIV-1/NN
)/)
is/VBZ
essential/JJ
for/IN
viral/JJ
replication/NN
and/CC
also/RB
shows/VBZ
pleiotropic/JJ
activities/NNS
on/IN
various/JJ
cell/NN
functions/NNS
./.
=====
To/TO
get/VB
further/JJ
insights/NNS
into/IN
the/DT
molecular/JJ
mechanisms/NNS
underlying/VBG
the/DT
biological/JJ
activity/NN
of/IN
Tat/NN
,/,
we/PRP
investigated/VBD
the/DT
effect/NN
of/IN
endogenous/JJ
and/CC
exogenous/JJ
Tat/NN
protein/NN
on/IN
c-fos/NN
gene/NN
expression/NN
in/IN
T/NN
lymphoblastoid/NN
(/(
Jurkat/NN
)/)
and/CC
monocytic/JJ
(/(
U937/NN
)/)
cell/NN
lines/NNS
,/,
as/RB
well/RB
as/IN
in/IN
primary/JJ
peripheral/JJ
blood/NN
mononuclear/JJ
cells/NNS
(/(
PBMC/NNS
)/)
./.
=====
Transient/JJ
cotransfection/NN
of/IN
tat/NN
cDNA/NN
in/IN
sense/JJ
orientation/NN
(/(
tat/S/NN
)/)
,/,
together/RB
with/IN
a/DT
plasmid/NN
containing/VBG
the/DT
c-fos/NN
promoter/NN
(/(
FC3/NN
,/,
from/IN
-711/CD
to/TO
+42/CD
)/)
in/IN
front/NN
of/IN
the/DT
bacterial/JJ
chloramphenicol/NN
acetyltransferase/NN
(/(
CAT/NN
)/)
gene/NN
significantly/RB
enhanced/VBD
CAT/NN
activity/NN
in/IN
Jurkat/NN
cells/NNS
activated/VBN
by/IN
the/DT
addition/NN
of/IN
15/CD
%/NN
fetal/JJ
calf/NN
serum/NN
(/(
FCS/NN
)/)
or/CC
5/CD
micrograms/mL/NNS
phytohemagglutinin/NN
plus/CC
10(-7)/CD
mol/L/NN
phorbol/NN
myristate/NN
acetate/NN
(/(
PMA/NN
)/)
and/CC
U937/NN
cells/NNS
activated/VBN
by/IN
15/CD
%/NN
FCS/NN
or/CC
10(-7)/CD
mol/L/NN
PMA/NN
./.
=====
This/DT
effect/NN
was/VBD
specifically/RB
due/JJ
to/TO
Tat/NN
,/,
since/IN
Jurkat/NN
and/CC
U937/NN
cells/NNS
cotransfected/VBN
either/CC
with/IN
tat/NN
cDNA/NN
in/IN
antisense/JJ
orientation/NN
(/(
tat/AS/NN
)/)
,/,
tat/NN
carrying/VBG
a/DT
mutation/NN
in/IN
the/DT
aminoacid/JJ
cys22-gly22/NN
(/(
tat/NN
22/S/NN
)/)
or/CC
with/IN
the/DT
backbone/NN
vector/NN
alone/RB
(/(
pRPneo-SL3/NN
)/)
did/VBD
not/RB
show/VB
any/DT
significant/JJ
difference/NN
in/IN
c-fos/NN
promoter/NN
activity/NN
as/IN
compared/VBN
to/TO
cells/NNS
transfected/VBN
with/IN
FC3/NN
plasmid/NN
alone/RB
./.
=====
By/IN
using/VBG
deletion/NN
mutants/NNS
of/IN
the/DT
c-fos/NN
promoter/NN
,/,
we/PRP
found/VBD
that/IN
the/DT
minimal/JJ
DNA/NN
sequence/NN
required/VBN
for/IN
Tat/NN
activity/NN
was/VBD
located/JJ
between/IN
nucleotides/NNS
-404/-220/CD
and/CC
that/IN
the/DT
serum/NN
responsive/JJ
element/NN
(/(
SRE/NN
,/,
-317/-288/CD
)/)
,/,
present/JJ
within/IN
this/DT
region/NN
,/,
was/VBD
still/RB
responsive/JJ
to/TO
Tat/NN
./.
=====
A/DT
single/JJ
point/NN
mutation/NN
in/IN
the/DT
SRE/NN
completely/RB
abrogated/VBD
the/DT
responsiveness/NN
to/TO
tat/S/NN
./.
=====
Exogenous/JJ
recombinant/JJ
Tat/NN
protein/NN
was/VBD
also/RB
able/JJ
to/TO
upregulate/VB
c-fos/NN
promoter/NN
activity/NN
in/IN
serum-activated/JJ
Jurkat/NN
and/CC
U937/NN
cells/NNS
,/,
as/RB
well/RB
as/IN
endogenous/JJ
c-fos/NN
mRNA/NN
expression/NN
and/CC
c-Fos/NN
protein/NN
synthesis/NN
in/IN
both/CC
serum-activated/JJ
cell/NN
lines/NNS
and/CC
primary/JJ
PBMC/NN
./.
=====
c-Fos/NN
protein/NN
was/VBD
shown/VBN
essential/JJ
for/IN
an/DT
optimal/JJ
transactivation/NN
of/IN
the/DT
HIV-1/NN
long/JJ
terminal/JJ
repeat/NN
(/(
LTR/NN
)/)
by/IN
Tat/NN
:/:
incubation/NN
of/IN
Jurkat/NN
cells/NNS
with/IN
antisense/JJ
,/,
but/CC
not/RB
sense/NN
,/,
c-fos/NN
oligonucleotides/NNS
significantly/RB
reduced/VBD
either/CC
the/DT
Tat-enhanced/JJ
expression/NN
of/IN
an/DT
LTR-CAT/NN
reporter/NN
construct/NN
or/CC
the/DT
levels/NNS
of/IN
gag/NN
p24/NN
in/IN
the/DT
culture/NN
supernatants/NNS
of/IN
Jurkat/NN
cells/NNS
and/CC
PBMC/NN
acutely/RB
infected/VBN
with/IN
HIV-1/NN
./.
=====
Our/PRP$
data/NNS
suggest/VBP
that/IN
the/DT
c-fos/NN
upregulation/NN
mediated/VBN
by/IN
Tat/NN
might/MD
play/VB
a/DT
significant/JJ
role/NN
in/IN
the/DT
control/NN
of/IN
viral/JJ
gene/NN
transactivation/NN
./.